---
title: "The economic value of personalized medicine tests | Sutter Health"
description: "Many personalized medicine tests have been found to be relatively cost-effective, although fewer have been found to be cost saving."
url: "https://www.sutterhealth.org/research/publications/economic-value-of-personalized-medicine-tests-1055312815"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Research publications](https://www.sutterhealth.org/research/publications) /
4.  The economic value of personalized medicine tests

# The economic value of personalized medicine tests: what we know and what we need to know.

Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang SY, & Neumann P.

_Genet Med. 16(3):251-7. doi: 10.1038/gim.2013.122. Epub 2013 Oct 17._

2014-03-01

## Abstract

PURPOSE: There is uncertainty about when personalized medicine tests provide economic value. We assessed evidence on the economic value of personalized medicine tests and gaps in the evidence base.

METHODS: We created a unique evidence base by linking data on published cost-utility analyses from the Tufts Cost-Effectiveness Analysis Registry with data measuring test characteristics and reflecting where value analyses may be most needed: (i) tests currently available or in advanced development, (ii) tests for drugs with Food and Drug Administration labels with genetic information, (iii) tests with demonstrated or likely clinical utility, (iv) tests for conditions with high mortality, and (v) tests for conditions with high expenditures.

RESULTS: We identified 59 cost-utility analyses studies that examined personalized medicine tests (1998-2011). A majority (72%) of the cost/quality-adjusted life year ratios indicate that testing provides better health although at higher cost, with almost half of the ratios falling below $50,000 per quality-adjusted life year gained. One-fifth of the results indicate that tests may save money.

CONCLUSION: Many personalized medicine tests have been found to be relatively cost-effective, although fewer have been found to be cost saving, and many available or emerging medicine tests have not been evaluated. More evidence on value will be needed to inform decision making and assessment of genomic priorities.

[PubMed abstract](http://www.ncbi.nlm.nih.gov/pubmed/24232413)

![Su-Ying Liang, Ph.D.](https://dyn.mktgcdn.com/p/cRIUee_GK3HEL1Wq8svqoUApvABjlwVVA-KUHVGzuNw/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100)

Su-Ying Liang, Ph.D.

Principal investigator

[View profile](https://www.sutterhealth.org/research/investigators/su-ying-liang-phd-1049681030)

## Research topics

-   [Disease Management](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Disease+Management%5C%22%22)
-   [Health Policy](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Health+Policy%5C%22%22)
-   [Medical Informatics](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Medical+Informatics%5C%22%22)

## Related publications

[View all publications](https://www.sutterhealth.org/research-search-results?verticalKey=research_publication)

-   Publication
    
    ### [Determinants of antidepressant treatment compliance: implications for policy.](https://www.sutterhealth.org/research/publications/determinants-antidepressant-tx-compliance-1055312587)
    
    Tai-Seale M, Croghan TW, Obenchain R.
    
    Med Care Res Rev. 57(4):491-512.
    
    2000 Dec 01
    
-   Publication
    
    ### [Determinants of generic drug substitution in the United States.](https://www.sutterhealth.org/research/publications/determinants-of-generic-drug-substitution-in-the-us-1055312368)
    
    Segal JB, Onasanya O, Daubresse M, Lee CY, Moechtar M, Pu X, Dutcher SK, Romanelli RJ.
    
    Ther Innov Regul Sci. 2168479018820050. doi: 10.1177/2168479018820050. \[Epub ahead of print\]
    
    2019 Jan 13
    
-   Publication
    
    ### [Beyond the threshold: real-time use of evidence in practice.](https://www.sutterhealth.org/research/publications/real-time-use-of-evidence-in-practice-1055312689)
    
    Jones JB, Stewart WF, Darer JD, Sittig DF.
    
    BMC Med Inform Decis Mak. 13:47. doi: 10.1186/1472-6947-13-47.
    
    2013 Apr 15
    
-   Publication
    
    ### [What will it take to reduce the app gap?](https://www.sutterhealth.org/research/publications/what-will-it-take-to-reduce-app-gap-1055312511)
    
    Paget L, Frosch DL.
    
    J Gen Intern Med. \[Epub ahead of print\]
    
    2016 Aug 04
    
-   Publication
    
    ### [Policy-oriented research on improved physician incentives for higher value health care.](https://www.sutterhealth.org/research/publications/improved-md-incentives-higher-value-healthcare-1055312438)
    
    Luft HS.
    
    Health Serv Res. doi: 10.1111/1475-6773.12423. \[Epub ahead of print\]
    
    2015 Nov 17
    

[View all publications](https://www.sutterhealth.org/research-search-results?verticalKey=research_publication)

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/publications/economic-value-of-personalized-medicine-tests-1055312815#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Research publications","item":"https://www.sutterhealth.org/research/publications"},{"@type":"ListItem","position":4,"name":"The economic value of personalized medicine tests"}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalScholarlyArticle","@id":"https://www.sutterhealth.org/research/publications/economic-value-of-personalized-medicine-tests-1055312815#medicalscholarlyarticle","name":"The economic value of personalized medicine tests: what we know and what we need to know.","headline":"The economic value of personalized medicine tests","abstract":"PURPOSE: There is uncertainty about when personalized medicine tests provide economic value. We assessed evidence on the economic value of personalized medicine tests and gaps in the evidence base. METHODS: We created a unique evidence base by linking data on published cost-utility analyses from the Tufts Cost-Effectiveness Analysis Registry with data measuring test characteristics and reflecting where value analyses may be most needed: (i) tests currently available or in advanced development, (ii) tests for drugs with Food and Drug Administration labels with genetic information, (iii) tests with demonstrated or likely clinical utility, (iv) tests for conditions with high mortality, and (v) tests for conditions with high expenditures. RESULTS: We identified 59 cost-utility analyses studies that examined personalized medicine tests (1998-2011). A majority (72%) of the cost/quality-adjusted life year ratios indicate that testing provides better health although at higher cost, with almost half of the ratios falling below $50,000 per quality-adjusted life year gained. One-fifth of the results indicate that tests may save money. CONCLUSION: Many personalized medicine tests have been found to be relatively cost-effective, although fewer have been found to be cost saving, and many available or emerging medicine tests have not been evaluated. More evidence on value will be needed to inform decision making and assessment of genomic priorities.","description":"Many personalized medicine tests have been found to be relatively cost-effective, although fewer have been found to be cost saving.","keywords":["Disease Management","Health Policy","Medical Informatics"],"datePublished":"2014-03-01","url":"https://www.sutterhealth.org/research/publications/economic-value-of-personalized-medicine-tests-1055312815","inLanguage":"en-US","identifier":[{"@type":"PropertyValue","propertyID":"PMID","value":"24232413"},{"@type":"PropertyValue","propertyID":"DOI","value":"10.1038/gim.2013.122"}],"sameAs":["https://pubmed.ncbi.nlm.nih.gov/24232413/","https://doi.org/10.1038/gim.2013.122"],"isPartOf":{"@type":"Periodical","name":"Genet Med"},"author":[{"@type":"Person","name":"Phillips KA"},{"@type":"Person","name":"Ann Sakowski J"},{"@type":"Person","name":"Trosman J"},{"@type":"Person","name":"Douglas MP"},{"@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/su-ying-liang-phd-1049681030","name":"Liang SY","url":"https://www.sutterhealth.org/research/investigators/su-ying-liang-phd-1049681030"},{"@type":"Person","name":"Neumann P"}],"sourceOrganization":{"@type":"MedicalOrganization","name":"Palo Alto Medical Foundation Research Institute"},"about":[{"@type":"DefinedTerm","name":"Disease Management","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Disease+Management%22%5D%7D%5D&verticalKey=research_publication"},{"@type":"DefinedTerm","name":"Health Policy","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Health+Policy%22%5D%7D%5D&verticalKey=research_publication"},{"@type":"DefinedTerm","name":"Medical Informatics","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Medical+Informatics%22%5D%7D%5D&verticalKey=research_publication"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://www.sutterhealth.org/research/publications/economic-value-of-personalized-medicine-tests-1055312815","breadcrumb":{"@id":"https://www.sutterhealth.org/research/publications/economic-value-of-personalized-medicine-tests-1055312815#breadcrumblist"}}}
```
